Cargando…
Clinicopathological Profile of a Cohort of Patients With Malignant Melanoma in the United Kingdom
Introduction Malignant melanoma (MM) is potentially a fatal type of skin cancer and a major health concern for the Caucasian population. It is a heterogeneous disease with a wide spectrum of manifestations. Therefore, in this study, we evaluated the clinicopathological characteristics of MM. Methods...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315104/ https://www.ncbi.nlm.nih.gov/pubmed/37404434 http://dx.doi.org/10.7759/cureus.39874 |
_version_ | 1785067444333707264 |
---|---|
author | Haroon, Saroona Vithanage, Iresha Rashid, Khushbakht Aslam, Mahnoor Elmahdy, Heba Zia, Shamail Malik, Umair Arshad Irfan, Muhammad Hashmi, Atif A |
author_facet | Haroon, Saroona Vithanage, Iresha Rashid, Khushbakht Aslam, Mahnoor Elmahdy, Heba Zia, Shamail Malik, Umair Arshad Irfan, Muhammad Hashmi, Atif A |
author_sort | Haroon, Saroona |
collection | PubMed |
description | Introduction Malignant melanoma (MM) is potentially a fatal type of skin cancer and a major health concern for the Caucasian population. It is a heterogeneous disease with a wide spectrum of manifestations. Therefore, in this study, we evaluated the clinicopathological characteristics of MM. Methods We retrospectively studied the clinicopathological characteristics of MM in 167 biopsy-proven cases of MM reported between January 2020 and December 2021 at Kings Mill Hospital, Sutton-in-Ashfield, United Kingdom. Clinical data such as the age, sex, and anatomical site of the lesion were obtained from the clinical referral forms. Biopsies of the lesions were performed, and the specimens collected were sent to the laboratory for histopathological study and v-raf murine sarcoma viral oncogene homolog B1 (BRAF) mutation evaluation. Formalin-fixed paraffin-embedded blocks (FFPE) were prepared, sectioned, and stained with hematoxylin and eosin for histological examination. Results A total of 167 cases of MM were included in the study. The age range was 23-96 years, with the median age at diagnosis found to be 66 years; males were more commonly affected (52.1%). The median Breslow thickness was 1.20 mm. The median mitotic activity was 1.0/mm(2). The lower limb was the most common site of involvement (27.5%), followed by the thorax (25.1%). The most common histological subtype was superficial spreading melanoma (SSM) (77.8%), followed by nodular melanoma (14.4%). The in situ component was present in 95.8% of cases; a majority (92.2%) of the cases showed vertical growth phase, 71.9% of cases were at Clark’s level IV of invasion, regression was noted in 70.7% of cases, ulceration was present in 21.6% of cases, and microsatellites were present in 3% of cases. Perineural invasion was present in 3% of cases, and lymphovascular invasion (LVI) was present in 4.2% of cases. BRAF mutation testing was performed on 36 cases, out of which 20 cases (55.6%) showed BRAF mutation. Acral lentiginous melanoma and nodular melanoma were most likely to show ulceration (66.7% and 37.5%, respectively). SSM and lentigo maligna melanoma were more likely to be associated with regression. Conclusion The study demonstrated that MM is prevalent among the elderly population with male predominance; SSM was found to be the most common subtype. The study further demonstrated various clinicopathological features of MM and its association with histological subtypes. |
format | Online Article Text |
id | pubmed-10315104 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-103151042023-07-03 Clinicopathological Profile of a Cohort of Patients With Malignant Melanoma in the United Kingdom Haroon, Saroona Vithanage, Iresha Rashid, Khushbakht Aslam, Mahnoor Elmahdy, Heba Zia, Shamail Malik, Umair Arshad Irfan, Muhammad Hashmi, Atif A Cureus Dermatology Introduction Malignant melanoma (MM) is potentially a fatal type of skin cancer and a major health concern for the Caucasian population. It is a heterogeneous disease with a wide spectrum of manifestations. Therefore, in this study, we evaluated the clinicopathological characteristics of MM. Methods We retrospectively studied the clinicopathological characteristics of MM in 167 biopsy-proven cases of MM reported between January 2020 and December 2021 at Kings Mill Hospital, Sutton-in-Ashfield, United Kingdom. Clinical data such as the age, sex, and anatomical site of the lesion were obtained from the clinical referral forms. Biopsies of the lesions were performed, and the specimens collected were sent to the laboratory for histopathological study and v-raf murine sarcoma viral oncogene homolog B1 (BRAF) mutation evaluation. Formalin-fixed paraffin-embedded blocks (FFPE) were prepared, sectioned, and stained with hematoxylin and eosin for histological examination. Results A total of 167 cases of MM were included in the study. The age range was 23-96 years, with the median age at diagnosis found to be 66 years; males were more commonly affected (52.1%). The median Breslow thickness was 1.20 mm. The median mitotic activity was 1.0/mm(2). The lower limb was the most common site of involvement (27.5%), followed by the thorax (25.1%). The most common histological subtype was superficial spreading melanoma (SSM) (77.8%), followed by nodular melanoma (14.4%). The in situ component was present in 95.8% of cases; a majority (92.2%) of the cases showed vertical growth phase, 71.9% of cases were at Clark’s level IV of invasion, regression was noted in 70.7% of cases, ulceration was present in 21.6% of cases, and microsatellites were present in 3% of cases. Perineural invasion was present in 3% of cases, and lymphovascular invasion (LVI) was present in 4.2% of cases. BRAF mutation testing was performed on 36 cases, out of which 20 cases (55.6%) showed BRAF mutation. Acral lentiginous melanoma and nodular melanoma were most likely to show ulceration (66.7% and 37.5%, respectively). SSM and lentigo maligna melanoma were more likely to be associated with regression. Conclusion The study demonstrated that MM is prevalent among the elderly population with male predominance; SSM was found to be the most common subtype. The study further demonstrated various clinicopathological features of MM and its association with histological subtypes. Cureus 2023-06-02 /pmc/articles/PMC10315104/ /pubmed/37404434 http://dx.doi.org/10.7759/cureus.39874 Text en Copyright © 2023, Haroon et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Dermatology Haroon, Saroona Vithanage, Iresha Rashid, Khushbakht Aslam, Mahnoor Elmahdy, Heba Zia, Shamail Malik, Umair Arshad Irfan, Muhammad Hashmi, Atif A Clinicopathological Profile of a Cohort of Patients With Malignant Melanoma in the United Kingdom |
title | Clinicopathological Profile of a Cohort of Patients With Malignant Melanoma in the United Kingdom |
title_full | Clinicopathological Profile of a Cohort of Patients With Malignant Melanoma in the United Kingdom |
title_fullStr | Clinicopathological Profile of a Cohort of Patients With Malignant Melanoma in the United Kingdom |
title_full_unstemmed | Clinicopathological Profile of a Cohort of Patients With Malignant Melanoma in the United Kingdom |
title_short | Clinicopathological Profile of a Cohort of Patients With Malignant Melanoma in the United Kingdom |
title_sort | clinicopathological profile of a cohort of patients with malignant melanoma in the united kingdom |
topic | Dermatology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315104/ https://www.ncbi.nlm.nih.gov/pubmed/37404434 http://dx.doi.org/10.7759/cureus.39874 |
work_keys_str_mv | AT haroonsaroona clinicopathologicalprofileofacohortofpatientswithmalignantmelanomaintheunitedkingdom AT vithanageiresha clinicopathologicalprofileofacohortofpatientswithmalignantmelanomaintheunitedkingdom AT rashidkhushbakht clinicopathologicalprofileofacohortofpatientswithmalignantmelanomaintheunitedkingdom AT aslammahnoor clinicopathologicalprofileofacohortofpatientswithmalignantmelanomaintheunitedkingdom AT elmahdyheba clinicopathologicalprofileofacohortofpatientswithmalignantmelanomaintheunitedkingdom AT ziashamail clinicopathologicalprofileofacohortofpatientswithmalignantmelanomaintheunitedkingdom AT malikumairarshad clinicopathologicalprofileofacohortofpatientswithmalignantmelanomaintheunitedkingdom AT irfanmuhammad clinicopathologicalprofileofacohortofpatientswithmalignantmelanomaintheunitedkingdom AT hashmiatifa clinicopathologicalprofileofacohortofpatientswithmalignantmelanomaintheunitedkingdom |